WebDisclosure WebDisclosure
Basculer en Français
11191 Companies
247562 Keywords
175392 Articles
133786 Press releases
Headlines Articles Press releases Aytu BioPharma, Inc. Remove
  1. Home
  2. Companies
  3. Aytu BioPharma, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/05/2025 at 23:55, 1 year 8 months ago

    Aytu BioPharma to Announce Q2 2025 Financial Results

    Financial Results Conference Call Pharmaceuticals Webcast Aytu BioPharma
  • BRIEF

    published on 02/05/2025 at 23:55, 1 year 8 months ago

    Aytu BioPharma annoncera ses résultats financiers du deuxième trimestre 2025

    Résultats Financiers Webcast Conférence Téléphonique Médicaments Aytu BioPharma
  • PRESS RELEASE

    published on 02/05/2025 at 23:50, 1 year 8 months ago

    Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

    Aytu BioPharma, Inc. to report Q2 fiscal 2025 results on Feb 12, 2025. Conference call and webcast scheduled for investors and analysts
    Financial Results Conference Call Webcast Q2 Fiscal 2025 Aytu BioPharma
    Logo of Aytu BioPharma, Inc.
Accesswire
  • Published on 10/17/2026 at 03:20, 1 day 4 hours ago

    Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments

  • Published on 10/17/2026 at 03:15, 1 day 4 hours ago

    Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry

  • Published on 10/16/2026 at 23:35, 1 day 7 hours ago

    Initial Closing of US$3.4 Million Private Placement

  • Published on 10/16/2026 at 23:30, 1 day 7 hours ago

    NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials

  • Published on 10/16/2026 at 23:00, 1 day 8 hours ago

    Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE
EQS Group
  • Published on 10/17/2026 at 18:00, 13 hours 24 minutes ago

    Baader Bank announces extended trading hours 23 hours a day starting Q1/2027

  • Published on 10/17/2026 at 13:05, 18 hours 19 minutes ago

    Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026

  • Published on 10/17/2026 at 12:50, 18 hours 34 minutes ago

    AGFUND wins international award for excellence in inclusive banking and social impact

  • Published on 10/16/2026 at 20:08, 1 day 11 hours ago

    EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme

  • Published on 10/16/2026 at 19:20, 1 day 12 hours ago

    Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation

View all EQS
Les Echos
  • Published on 10/16/2026 at 19:54, 1 day 11 hours ago

    ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026

  • Published on 10/16/2026 at 18:48, 1 day 12 hours ago

    Disclosure of transactions in own shares from October 12 to October 16, 2026

  • Published on 10/16/2026 at 18:48, 1 day 12 hours ago

    Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026

  • Published on 10/16/2026 at 18:00, 1 day 13 hours ago

    KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026

  • Published on 10/16/2026 at 07:30, 1 day 23 hours ago

    Third Quarter Revenues 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy